Label: TREDA ULTRA- bismuth subsalicylate tablet
- NDC Code(s): 83393-749-08
- Packager: Laboratorios Sanfer, S.A. de C.V.
- Category: HUMAN OTC DRUG LABEL
- DEA Schedule: None
Drug Label Information
Updated February 6, 2024
If you are a consumer or patient please visit this version.
- Download DRUG LABEL INFO: PDF XML
- Official Label (Printer Friendly)
- Active ingredient (in each caplet)
- Purpose
- Uses
-
Warnings
Reye's syndrome: Children and teenagers who have or are recovering from chicken pox or flu-like symptoms should not use this product. When using this product, if changes in behavior with nausea and vomiting occur, consult a doctor because these symptoms could be an early sign of Reye's syndrome, a rare but serious illness.
Allergy alert: Contains salicylate. Do not take if you are
- allergic to salicylates (including aspirin)
- taking other salicylate products
Ask a doctor or pharmacist before use if you are
taking any drug for
- gout
- diabetes
- arthritis
- anticoagulation (thinning the blood)
-
Directions
- do not take more than directed
- drink plenty of clear fluids to help prevent dehydration caused by diarrhea
- swallow with water; do not chew
- adults and children 12 years and over: 1 caplet every 1/2 to 1 hour as needed. Do not exceed 8 caplets in 24 hours.
- do not use for more than 2 days unless directed by a doctor
- use until diarrhea stops, but not more than 2 days
- children under 12 years: ask a doctor
- Other information
- Inactive ingredients
- Questions or comments?
-
Principal display panel
Treda®
UltraBismuth Subsalicylate 525 mg
UPSET STOMACH RELIEVER
ANTIDIARRHEAL
RELIEVES:
Diarrhea
Nausea
Heartburn
Upset Stomach
Indigestion
Actual Size
24
caplets
sanfer®
TAMPER EVIDENT: DO NOT USE IF IMPRINTED
SAFETY SEAL UNDER CAP IS BROKEN OR MISSING50844
ORG032174908Manufactured for: Laboratorios Sanfer S.A. de C.V.
Blvd. Adolfo López Mateos No. 314
Col. Tlacopac, CDMX, 01049. MéxicoThis product is produced in compliance with all United
States regulatory and quality requirements for
pharmaceutical product.Treda Ultra 44-749
-
INGREDIENTS AND APPEARANCE
TREDA ULTRA
bismuth subsalicylate tabletProduct Information Product Type HUMAN OTC DRUG Item Code (Source) NDC:83393-749 Route of Administration ORAL Active Ingredient/Active Moiety Ingredient Name Basis of Strength Strength BISMUTH SUBSALICYLATE (UNII: 62TEY51RR1) (SALICYLIC ACID - UNII:O414PZ4LPZ, BISMUTH CATION - UNII:ZS9CD1I8YE) BISMUTH SUBSALICYLATE 525 mg Inactive Ingredients Ingredient Name Strength CALCIUM CARBONATE (UNII: H0G9379FGK) STARCH, CORN (UNII: O8232NY3SJ) D&C RED NO. 27 ALUMINUM LAKE (UNII: ZK64F7XSTX) D&C RED NO. 30 (UNII: 2S42T2808B) MAGNESIUM STEARATE (UNII: 70097M6I30) MANNITOL (UNII: 3OWL53L36A) MICROCRYSTALLINE CELLULOSE (UNII: OP1R32D61U) POVIDONE, UNSPECIFIED (UNII: FZ989GH94E) SILICON DIOXIDE (UNII: ETJ7Z6XBU4) SODIUM STARCH GLYCOLATE TYPE A POTATO (UNII: 5856J3G2A2) STEARIC ACID (UNII: 4ELV7Z65AP) Product Characteristics Color pink Score no score Shape OVAL Size 19mm Flavor Imprint Code 44;749 Contains Packaging # Item Code Package Description Marketing Start Date Marketing End Date 1 NDC:83393-749-08 1 in 1 CARTON 02/06/2024 1 24 in 1 BOTTLE, PLASTIC; Type 0: Not a Combination Product Marketing Information Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date OTC Monograph Drug M008 02/06/2024 Labeler - Laboratorios Sanfer, S.A. de C.V. (810007732)